Jasmine A. Tuazon

Jasmine A. Tuazon studies natural killer (NK) cells, a type of immune cell that helps control infections and tumors, focusing on how molecules like the RNA helicase DDX3X and receptors such as CXCR3 and LAG-3 regulate NK cell survival and immune-suppressing functions. Her work also explores engineering NK cells with chimeric antigen receptors (CAR-NK cells) as a potential cell-based therapy, and she has separately written about challenges facing physician-scientist trainees. Prospective students would likely engage with basic immunology techniques alongside translational cell-therapy approaches.

Publication output has grown over the past decade, rising from about 1 paper per year in 2017-2018 to a peak of 7 in 2025, with a recent average of about 4 papers per year.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026